Antibiotics   General  Above the diaphragm (Aspiration pneumonia, lung abscesses, oral infections)   Below the Diaphragm (Intra-abdominal anaerobic infections)   Monitoring  Aminoglycosides/Vancomycin If IV ≥3 days or ≥2 days in a renal patient      Penicillin causing rash Not a contraindication for cephalosporins  Breathing issues, edema are CIs      Amoxicillin/Clavulanic Acid (Augmentin)  Ampicillin/Sulbactam (Unasyn)  Ceftriaxone  SE: Cholestasis  Cefazolin  Prophylaxis for skin flora  Cefepime  Coverage Pseudomonas, MSSA, Strep Pneumo, H. Influenzae      Misses   SE: Neutropenia, thrombocytopenia, Seizure, Delirium, C. Difficile, Transaminitis, Hemolytic anemia, interstitial nephritis  Ceftaroline  5th  gen cephalosporin, only one that covers MRSA  Clindamycin  MOA: Inhibits protein synthesis  Effective against Bacteroides and c. perfringens  Chloramphenicol  50S static  Associated w/ blood dyscrasias  Daptomycin (Cubicin)  Can be considered for MRSA infections when the isolate's vancomycin MIC is ≥2 nanograms/mL or when the vancomycin MIC is close to 2 nanograms/mL and the clinical response is poor Test susceptibility first      Coverage   SE: LFT elevations, Acute eosinophilic pneumonia, peripheral neuropathy, Falsely elevated INR, Rhabdomyolysis (CK (DC if ≥2000 or ≥1000 w/myopathy), stop statins)  Meropenem (Merrem)  Coverage   Metronidazole  MOA: Contains a nitro group that acts as an electron sink, capturing electrons and creating free radicals which disrupts DNA synthesis via a cytotoxic intermediate (Bactericidal)  Effective against Bacteroides, prevotella, fusobacterium, clostridium  SE: Disulfiram-like reaction (severe flushing, tachycardia, palpitations, nausea, vomiting, hypotension) with alcohol  Metallic taste  Headache      Piperacillin-Tazobactam (Zosyn)  Coverage   Misses   SE: Rash, Drug fever, Prolonged PT, Leukopenia, Thrombocytopenia  Telavancin  Lipoglycopeptide derivative of vancomycin and can be given once daily  More side effects than Vancomycin, worse kidney injury  Tuberculosis Medications  Rifampin Benign, red color to body secretions      Isoniazid Peripheral Neuropathy  Use pyridoxine to prevent      Pyrazinamide Benign, Hyperuricemia (Gout)      Ethambutol Optic neuritis/color vision changes  Decrease dose in renal failure      TMP/SMX  CI: Warfarin/Methotrexate use, allergy, elderly with renal insufficiency  Vancomycin  Red Man Syndrome MC adverse event, hypersensitivity not reaction  Usually 5-10 minutes after starting infusion  Diffuse erythema, pruritus, and tenderness over the skin above the waist  ± hypotension, dyspnea if severe  Treatment  Stop infusion, give antihistamines, restart infusion at slower rate      Dosing Guidelines Area under the curve, Mean inhibitory concentration  Goal for AUC/MIC to be achieved in 24-48 hours      Empiric Therapy AUC/MIC calculation for empiric therapy assumes MIC to be 1 nanogram/ml or less      MRSA Native Tricuspid Valve Endocarditis AUC/MIC target of 400-600 mg*hour/L of Vancomycin to maximize efficacy and minimize nephrotoxicity      MRSA Prosthetic Valve Endocarditis Vancomycin, Gentamicin, and Rifampin                    Back to top